Whistleblower: Pfizer vaccine trial data was falsified, participants who experienced adverse effects were ignored

Source: https://www.naturalnews.com/2021-11-11-pfizer-falsified-trial-data-vaccine-adverse-effects.html

A private clinical research company involved in the Pfizer Wuhan coronavirus (COVID-19) vaccine trial in the fall of 2020 falsified phase-three trial data and neglected participants who experienced adverse events.

This is according to the testimony of whistleblower Brook Jackson, a clinical trial auditor with more than 15 years of experience in clinical research coordination and management. Jackson worked for Ventavia Research Group, a clinical research company based in Texas, for two weeks in Sept. 2020.

During her stint at Ventavia, Jackson repeatedly alerted her employer to the overwhelming number of problems in quality control of the trial. She even emailed her complaints to the Food and Drug Administration (FDA). But all of her concerns were ignored and her employer fired her on the same day she reported her concerns to the FDA.

Paul. D. Thacker, who handled the BMJ’s report on Jackson’s testimony, wrote that the medical journal is in possession of “dozens of internal company documents, photos, audio recordings and emails” – thanks to Jackson.

One of the photos in the BMJ’s possession reportedly shows “vaccine packaging materials with trial participants’ identification numbers written on them left out in the open, potentially unblinding participants.”

Keeping trials double-blind is an important aspect that maintains the integrity of randomized control trials. It protects data from being influenced by bias, and researchers dedicated to science and facts should at all times maintain the blinding of research facilitators and participants.

But when Jackson took the photo of the packaging materials, Ventavia executives questioned her and reprimanded her.

Patrick Delaney, writing for Life Site News, pointed out that some clinical research companies may have financial incentives to break research protocols and unblind participants to produce outcomes favorable to their clients. “In this case, Pfizer, and their knowledge of trial participants’ status may bias them in how they collect data,” he wrote.

According to Jackson’s email to the FDA, she had many other issues regarding Ventavia’s Pfizer trial, including:

• Post-injection participants were ignored by clinical staff.
• Patients who experienced adverse reactions to the vaccinations were not followed-up with on time.
• Protocol deviations were not being reported.
• Vaccines were not stored at proper temperatures.
• Laboratory specimens were routinely mislabeled.
• Ventavia executives harassed staff who reported concerns about the way the trial was conducted.

banned.video – MSM Can’t Hide Adverse Reactions Forever

Source: https://banned.video/watch?id=618c14eaec8dc93f16cb7f27

Steve Kirsch – New VAERS analysis reveals hundreds of serious adverse events that the CDC and FDA never told us about

They missed hundreds of serious adverse events that are more elevated than myocarditis. A new VAERS analysis done by Albert Benavides blows the doors off the “safe and effective” narrative.

Source: https://stevekirsch.substack.com/p/new-vaers-analysis-reveals-hundreds

The CDC and FDA have said the vaccines are “safe and effective.” They haven’t found any serious issues with the COVID vaccines. Zero. Zip. Nada. It was the DoD that found myocarditis.

The evidence in plain sight shows that they are either lying or incompetent. Or both. But of course, the medical community is never going to call them on this.

C19 count
This is the raw number of VAERS events in 2020 and 2021 due to the COVID vaccines for that symptom. The key here is that this count should be multiplied by 41 (known as the underreporting factor or URF to estimate the absolute number of events that occurred). See this article for how that is computed.

Baseline count
The baseline rate is the # of incidents occurring in a 5 year period from 2015-2019 for all vaccines given in that time period.

X-factor
The X-factor is the (C19 count*5/Baseline count). This is because the baseline is 5 years so we compare the COVID counts in a year vs. the average count in a typical year. So an X-factor of 10 or more would mean that the symptom is very likely to be caused by the vaccine since it is highly elevated from the “normal” rate.

Now let’s tackle the tabs. There are two tabs:

match tab
On the match tab are symptoms where the baseline count !=0

no match tab
On the “no match” tab are symptoms where the baseline count=0. So these are quite extraordinary since these symptoms are not typically seen even once in 5 years. So here, even a small value in the “count” field is very significant, e.g., 2 or more would be comparable to a 10X or more on the “match tab.”

Now here are some screenshots of the first page of the two tabs:

And the no match tab:

What the data tells us

Here are a few quick observations from the complete data set (see next section for downloading):

1. Female reproductive issues top the list. These are strongly elevated by these vaccines. Many of the top symptoms are all related to the menstrual process.
2. There are an enormous number of cardiovascular and neurological events that are strongly elevated, many of them serious.
3. Fibrin D dimer increased is #53 on the list, elevated by a factor of over 400x above baseline. Charles Hoffe discovered D-dimer was elevated in over 60% of the patients he measured. This is very serious as D-dimer is a lagging indicator of blood clots.
4. Troponin increased was #130, elevated by a factor of 205. Troponin indicates heart damage and it is elevated to extreme levels (10X heart attack levels or more) and can stay elevated for months at a time (with a heart attack, the levels start returning back to normal immediately after the incident)
5. Death as a symptom (which is pretty unusual coding since it isn’t a symptom), is #433 and elevated by 96X. Hardly a “safe” vaccine.
6. Brain herniation at #405 is elevated by a factor of 100X over baseline. However, this is not considered a big deal at the CDC (perhaps because many people there don’t use their brain).
7. Cardiac arrest at #450 is elevated by 93X. This is when your heart stops. This is a relatively serious condition since you don’t last for too long after that. It’s a bit surprising that the CDC missed that one. Perhaps because they don’t have a heart?
8. Pulmonary embolism #24 is elevated by 954 times normal. How the CDC can miss that one is simply astonishing! This was the cause of death of 2 of the 14 kids that the CDC looked at in their death analysis. Mainstream press will never ask them that question as to why the CDC would not find causality here. They wrote: “CDC reviewed 14 reports of death after vaccination. Among the decedents, four were aged 12–15 years and 10 were aged 16–17 years. All death reports were reviewed by CDC physicians; impressions regarding cause of death were pulmonary embolism (two), …” 954 times normal is hard to explain, isn’t it? So no causality? That’s hard to explain, so they didn’t. They just moved on as if there is nothing to see.
9. Intracranial haemorrhage (their spelling) is at #604 and is elevated by 79X. Two of the 14 kids from the CDC analysis died from that. How could that not be causal? They never explained that.
10. Tinnitus at #362 is elevated by 105X. This can be so bad that people can kill themselves from this alone. One of the people who work at Vaccine Safety Research Foundation (VSRF) had to talk a friend out of suicide.
11. There are many many more issues to be concerned with, but I wanted to get the list out quickly so there can be more eyes on this.
12. For months, I’ve offered to discuss our data and analyses to both the FDA and CDC outside committees as well as the CDC and FDA themselves, but nobody wanted to see it. Most hit delete on my emails. A few told me to wait for the public comment period and submit it then (which I’ve done). Nobody followed up.

InfoWars – Child, 7, Experiences Adverse Reaction After Mistakenly Being Given Adult Vaccine Dose During Trick-or-Treat Event

by Adan Salazar

Study : https://www.infowars.com/posts/child-7-experiences-adverse-reaction-after-mistakenly-being-given-adult-vaccine-dose-during-trick-or-treat-event/

To make matters worse, one of the children given the vaccine suffered adverse reaction following the vaccination.

The boy was cleared by a doctor, but will require monitoring to ensure no additional side effects persist.

The city released a statement acknowledging the shots were given in error:

“The City of Garland Health Department (GHD) is reporting that two children under the age of 12 were administered doses of the Pfizer vaccine in error this weekend. GHD officials are in communication with the parents of the children involved, who are monitoring the children for side effects. GHD also has reported the incident to state health officials and are further investigating the circumstances leading up to the error. The safety and privacy of our patients is always our top priority. Due to patient privacy, we cannot share additional information at this time.”

Meanwhile, the family wants to know how the error occurred and who’s responsible.

“We found out after the fact that the vials for the children’s vaccine should have been different, the needles should have been different…it should have been labeled specifically for kids so…where did that decision come from? Who was it that told them they could go ahead and offer it?” Gonzalez told the local media station, adding that he’s frustrated over the situation.

“We’re just on edge completely until we see this through.”

In an update Wednesday, CBS DFW reported that “The mother of the 7-year-old mistakenly given an adult COVID vaccine dose, says her son is doing ‘okay’ after getting the shot.”

CDC – Selected Adverse Events Reported after COVID-19 Vaccination

Source: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html

Serious adverse events after COVID-19 vaccination are rare but may occur.

For public awareness and in the interest of transparency, CDC is providing timely updates on the following serious adverse events of interest:

• Anaphylaxis after COVID-19 vaccination is rare and has occurred in approximately 2 to 5 people per million vaccinated in the United States. Severe allergic reactions, including anaphylaxis, can occur after any vaccination. If this occurs, vaccination providers can effectively and immediately treat the reaction. Learn more about COVID-19 vaccines and allergic reactions, including anaphylaxis.
• Thrombosis with thrombocytopenia syndrome (TTS) after Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccination is rare. As of October 27, 2021, more than 15.5 million doses of the J&J/Janssen COVID-19 Vaccine have been given in the United States. CDC and FDA identified 48 confirmed reports of people who got the J&J/Janssen COVID-19 Vaccine and later developed TTS.  Women younger than 50 years old especially should be aware of the rare but increased risk of this adverse event. There are other COVID-19 vaccine options available for which this risk has not been seen. Learn more about J&J/Janssen COVID-19 Vaccine and TTS.
  • To date, two confirmed cases of TTS following mRNA COVID-19 vaccination (Moderna) have been reported to VAERS after more than 401 million doses of  mRNA COVID-19 vaccines administered in the United States. Based on available data, there is not an increased risk for TTS after mRNA COVID-19 vaccination.
• CDC and FDA are monitoring reports of Guillain-Barré Syndrome (GBS) in people who have received the J&J/Janssen COVID-19 Vaccine. GBS is a rare disorder where the body’s immune system damages nerve cells, causing muscle weakness and sometimes paralysis. Most people fully recover from GBS, but some have permanent nerve damage. After more than 15.5 million J&J/Janssen COVID-19 Vaccine doses administered, there have been around 244 preliminary reports of GBS identified in VAERS as of October 27, 2021. These cases have largely been reported about 2 weeks after vaccination and mostly in men, many 50 years and older. CDC will continue to monitor for and evaluate reports of GBS occurring after COVID-19 vaccination and will share more information as it becomes available.
• Myocarditis and pericarditis after COVID-19 vaccination are rare. As of October 27, 2021, VAERS has received 1,784 reports of myocarditis or pericarditis among people ages 30 and younger who received COVID-19 vaccine. Most cases have been reported after mRNA COVID-19 vaccination (Pfizer-BioNTech or Moderna), particularly in male adolescents and young adults. Through follow-up, including medical record reviews, CDC and FDA have confirmed 1,005 reports of myocarditis or pericarditis. CDC and its partners are investigating these reports to assess whether there is a relationship to COVID-19 vaccination. Learn more about COVID-19 vaccines and myocarditis.
• Reports of death after COVID-19 vaccination are rare. More than 423 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020, through November 1, 2021. During this time, VAERS received 9,367 reports of death (0.0022%) among people who received a COVID-19 vaccine. FDA requires healthcare providers to report any death after COVID-19 vaccination to VAERS, even if it’s unclear whether the vaccine was the cause. Reports of adverse events to VAERS following vaccination, including deaths, do not necessarily mean that a vaccine caused a health problem. A review of available clinical information, including death certificates, autopsy, and medical records, has not established a causal link to COVID-19 vaccines. However, recent reports indicate a plausible causal relationship between the J&J/Janssen COVID-19 Vaccine and TTS, a rare and serious adverse event—blood clots with low platelets—which has caused deaths pdf icon[1.4 MB, 33 pages].

COVID-19 Vaccine Safety Updates
Advisory Committee on Immunization Practices (ACIP)
Oct 21, 2021
Tom Shimabukuro, MD, MPH, MBA
Vaccine Safety Team
CDC COVID-19 Vaccine Task Force

PDF: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-10-20-21/06-COVID-Shimabukuro-508.pdf